Alpha 1-antitrypsin serum concentration and phenotypes in ulcerative colitis

Area of Science:

• Gastroenterology
• Immunology
• Clinical Chemistry

Background:

• Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
• Alpha 1-antitrypsin (alpha 1-AT) is a key protease inhibitor in the body.
• The role of alpha 1-AT in UC pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the association between alpha 1-antitrypsin (alpha 1-AT) electrophoretic variants and ulcerative colitis.
• To assess serum alpha 1-AT concentrations in UC patients compared to healthy controls.
• To explore the correlation between serum alpha 1-AT levels and UC disease activity.

Main Methods:

• Electrophoretic typing of alpha 1-antitrypsin (alpha 1-AT) variants in 96 unrelated UC patients.
• Comparison of serum alpha 1-AT concentrations between UC patients and healthy controls.
• Statistical analysis to determine the correlation between serum alpha 1-AT levels and UC disease activity.

Main Results:

• No specific alpha 1-antitrypsin (alpha 1-AT) phenotype was found to be definitively associated with ulcerative colitis.
• UC patients exhibited significantly increased serum alpha 1-AT concentrations compared to healthy controls.
• A positive correlation was observed between serum alpha 1-AT levels and the clinical activity of ulcerative colitis.

Conclusions:

• Electrophoretic variants of alpha 1-antitrypsin (alpha 1-AT) do not appear to be a risk factor for ulcerative colitis.
• Elevated serum alpha 1-AT levels in UC patients may indicate an inflammatory response.
• Serum alpha 1-AT concentration serves as a potential biomarker for ulcerative colitis activity.